Literature DB >> 17348041

Spastin and microtubules: Functions in health and disease.

Sara Salinas1, Rafael E Carazo-Salas, Christos Proukakis, Giampietro Schiavo, Thomas T Warner.   

Abstract

SPG4, the gene encoding for spastin, a member of the ATPases associated with various cellular activities (AAA) family, is mutated in around 40% of cases of autosomal dominant hereditary spastic paraplegia (AD-HSP). This group of neurodegenerative diseases is characterized by a progressive spasticity and lower limb weakness with degeneration of terminal axons in cortico-spinal tracts and dorsal columns. Spastin has two main domains, a microtubule interacting and endosomal trafficking (MIT) domain at the N-terminus and the C-terminus AAA domain. Early studies suggested that spastin interacts with microtubules similarly to katanin, a member of the same subgroup of AAA. Recent evidence confirmed that spastin possesses microtubule-severing activity but can also bundle microtubules in vitro. Understanding the physiologic and pathologic involvement of these activities and their regulation is critical in the study of HSP. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17348041     DOI: 10.1002/jnr.21238

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  24 in total

1.  Molecular and genetic analysis of the Drosophila model of fragile X syndrome.

Authors:  Charles R Tessier; Kendal Broadie
Journal:  Results Probl Cell Differ       Date:  2012

2.  The microtubule-severing proteins spastin and katanin participate differently in the formation of axonal branches.

Authors:  Wenqian Yu; Liang Qiang; Joanna M Solowska; Arzu Karabay; Sirin Korulu; Peter W Baas
Journal:  Mol Biol Cell       Date:  2008-01-30       Impact factor: 4.138

3.  ClpXP protease degrades the cytoskeletal protein, FtsZ, and modulates FtsZ polymer dynamics.

Authors:  Jodi L Camberg; Joel R Hoskins; Sue Wickner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-17       Impact factor: 11.205

Review 4.  Hereditary spastic paraplegias: membrane traffic and the motor pathway.

Authors:  Craig Blackstone; Cahir J O'Kane; Evan Reid
Journal:  Nat Rev Neurosci       Date:  2011-01       Impact factor: 34.870

5.  Functional conservation of human Spastin in a Drosophila model of autosomal dominant-hereditary spastic paraplegia.

Authors:  Fang Du; Emily F Ozdowski; Ingrid K Kotowski; Douglas A Marchuk; Nina Tang Sherwood
Journal:  Hum Mol Genet       Date:  2010-02-13       Impact factor: 6.150

6.  Promotion of neurite extension by protrudin requires its interaction with vesicle-associated membrane protein-associated protein.

Authors:  Shotaro Saita; Michiko Shirane; Tohru Natume; Shun-Ichiro Iemura; Keiichi I Nakayama
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

7.  Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis.

Authors:  Michael C Levin; Sangmin Lee; Lidia A Gardner; Yoojin Shin; Joshua N Douglas; Chelsea Cooper
Journal:  J Clin Cell Immunol       Date:  2013-06-30

8.  Conserved pharmacological rescue of hereditary spastic paraplegia-related phenotypes across model organisms.

Authors:  Carl Julien; Alexandra Lissouba; Surya Madabattula; Yasmin Fardghassemi; Cory Rosenfelt; Alaura Androschuk; Joel Strautman; Clement Wong; Andrew Bysice; Julia O'sullivan; Guy A Rouleau; Pierre Drapeau; J Alex Parker; François V Bolduc
Journal:  Hum Mol Genet       Date:  2016-01-06       Impact factor: 6.150

Review 9.  Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

Authors:  Arthur H M Burghes; Christine E Beattie
Journal:  Nat Rev Neurosci       Date:  2009-07-08       Impact factor: 34.870

10.  Quantitative and functional analyses of spastin in the nervous system: implications for hereditary spastic paraplegia.

Authors:  Joanna M Solowska; Gerardo Morfini; Aditi Falnikar; B Timothy Himes; Scott T Brady; Dongyang Huang; Peter W Baas
Journal:  J Neurosci       Date:  2008-02-27       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.